New‐onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report

New‐onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report

Abstract Fulminant type 1 diabetes is characterized by a rapid progression of insulin deficiency triggered by viral infection. Here, we report a case of a 45‐year‐old Japanese woman with fulminant type 1 diabetes that developed 8 days after receiving messenger ribonucleic acid vaccine against severe...

Full description

Bibliographic Details
Main Authors: Keyaki Sasaki, Tomoaki Morioka, Natsumi Okada, Yuka Natsuki, Yoshinori Kakutani, Akinobu Ochi, Yuko Yamazaki, Tetsuo Shoji, Takashi Ohmura, Masanori Emoto
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Journal of Diabetes Investigation
Subjects:
Fulminant type 1 diabetes
Severe acute respiratory syndrome coronavirus 2
Vaccination
Online Access:https://doi.org/10.1111/jdi.13771

Internet

https://doi.org/10.1111/jdi.13771

Similar Items